Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Government launched the Flemish Defence Plan in April 2025 * , bringing together security, resilience and economic development. Knowledge institutions, including VIB, are actively involved, with the aim
-
high-quality results You will prepare and write technical reports to record data and/or results You stay up-to-date with emerging technologies in next gen sequencing, genomics, and transcriptomics
-
antibody specificity profiling. KEY RESPONSIBILITIES You’ll join a small team advancing a new screening platform focused on therapeutic antibody specificity. The aim is to deploy this newly developed assay
-
. Our mission is to move beyond descriptive biology and develop predictive, mechanistic models that connect molecular regulation to cellular and systems-level phenotypes. The Laboratory of Computational
-
accelerate breakthroughs in the understanding and treatment of neurodegenerative and neurological disorders. By combining deep mechanistic insight with translational ambition, the center aims to develop next
-
biology, and translational disease research, and offers strong opportunities for methodological development, interdisciplinary collaboration, and high-impact publications. Your profile We are looking
-
Leuven, Belgium and is part of the VIB-KU Leuven Center for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative
-
responsible for the design, operation, and future evolution of VIB Data Core’s on-premise and hybrid infrastructure that supports life sciences research. You will manage a team of infrastructure engineers and
-
centrosome is essential for early embryonic cell divisions, we still do not understand the profound “centrosome reduction” it undergoes during spermatogenesis and how this pathway impacts embryo development
-
the development of genetic autoinflammatory diseases. Using techniques in cell biology, molecular biology and biophysics you will investigate how loss of function of the RNA editing enzyme ADAR1 causes the human